How Leukemia Develops Over Decades - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

How Leukemia Develops Over Decades

  • November 17, 2026

  • 2 min

Share

Objective:

To track how AML-associated mutations and mutated blood-cell populations change before diagnosis, and assess whether these patterns distinguish people who later develop AML.

Approach:
  • Longitudinal samples: Researchers analyzed annual blood samples from 47 women who later developed AML and 46 age-matched controls who remained free of blood cancer.
  • Mutation tracking: Using TETRIS-seq, the team tracked AML-associated mutations and changes in the size of blood-cell populations carrying them.
  • Risk analysis: The researchers also analyzed UK Biobank data to assess whether extensive expansion of mutated cell populations was associated with myeloid leukemia.
Key Findings:
  • In about two-thirds of participants who developed AML, the first cancer-associated mutation was estimated to have appeared before age 20.
  • Mutated cell populations initially grew slowly; their growth accelerated as additional mutations accumulated, sometimes decades before clinical diagnosis.
  • Age-related mutations occurred in both groups, but future AML cases showed more extensive expansion and competition among mutated cell populations.
  • UK Biobank analysis found substantially increased odds of myeloid leukemia among individuals with evidence of extensive expansion of a mutated cell population.
Interpretation:

The findings suggest that assessing the extent of mutated-cell expansion, in addition to identifying mutations, may improve molecular risk assessment. The study does not establish a screening test.

Limitations:
  • The cohort was relatively small and consisted of older women.
  • About one-fifth of AML cases showed little detectable warning before diagnosis.
  • Further validation is needed to determine whether monitoring these changes can reliably identify high-risk individuals or guide preventive intervention.
Conclusion:

The study describes AML-associated genetic changes that can begin decades before diagnosis, while noting that the findings require further validation.

Sources:

Original Source(s)

Related Content